CORDIS
EU research results

CORDIS

English EN
New Molecular Purification Technology for Pharmaceutical Production

New Molecular Purification Technology for Pharmaceutical Production

Objective

The NEMOPUR Initial Training Network will focus on creating a new generation of molecular purification technologies for Active Pharmaceutical Ingredient (API) manufacture, with a particular focus on removal of organic impurities from API production. New membranes with improved chemical stability in a wide range of solvents, and better controlled cutoff properties, novel molecularly imprinted polymers with readily scalable production chemistries, and composite molecularly imprinted film – macroporous support membranes will be developed. The applications of these technologies will be through the industrial partners. The project is multidisciplinary, involving chemists, materials scientists and chemical engineers. The consortium is intersectorial, comprising 3 universities/research institutes, 2 technology SMEs and 4 pharmaceutical manufacturers, and will have a strong emphasis on knowledge creation, technology commercialisation, and entrepreneurship. The training programme involves Early Stage Researchers (ESR), at both university and industrial partners, each of whom will complete a PhD thesis through a combination of local and network wide research experience. Experienced Researchers (ER) will complete their training, focussing on knowledge transfer, commercialisation and entreprenuership skills. In addition to their individual research, ESR and ER will complete complementary training through a series of Personal Skills Modules, and a course on Technology Commercialisation and Entrepreurship. NEMOPUR seeks to contribute to improving the European knowledge supply chain through this industry-academia programme of applied research aimed at developing engineers and scientists who are academically excellent and achieve PhD degrees, but who thrive at the interface between fundamental research and industrial application.
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE

Address

South Kensington Campus Exhibition Road
Sw7 2az London

United Kingdom

Activity type

Higher or Secondary Education Establishments

EU Contribution

€ 690 527

Administrative Contact

Shaun Power (Mr.)

Participants (8)

Sort alphabetically

Sort by EU Contribution

Expand all

TECHNISCHE UNIVERSITAT DORTMUND

Germany

EU Contribution

€ 499 788

CONSIGLIO NAZIONALE DELLE RICERCHE

Italy

EU Contribution

€ 508 296

EVONIK MEMBRANE EXTRACTION TECHNOLOGY LIMITED

United Kingdom

EU Contribution

€ 217 022

Biotage

Sweden

EU Contribution

€ 209 759

HOVIONE FARMACIENCIA SA

Portugal

EU Contribution

€ 184 873

UCB PHARMA SA

Belgium

EU Contribution

€ 197 102

GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.

United Kingdom

EU Contribution

€ 210 186

LONZA AG

Switzerland

EU Contribution

€ 220 280

Project information

Grant agreement ID: 214226

Status

Closed project

  • Start date

    1 September 2008

  • End date

    31 August 2012

Funded under:

FP7-PEOPLE

  • Overall budget:

    € 2 937 833

  • EU contribution

    € 2 937 833

Coordinated by:

IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE

United Kingdom